These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10717578

  • 21. The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.
    Winston A, McAllister J, Amin J, Cooper DA, Carr A.
    HIV Med; 2005 May; 6(3):191-7. PubMed ID: 15876286
    [Abstract] [Full Text] [Related]

  • 22. Newly approved PI provides treatment options.
    AIDS Alert; 1997 Jun; 12(6):68-9. PubMed ID: 11364360
    [Abstract] [Full Text] [Related]

  • 23. Nelfinavir - major trial results at retroviruses conference.
    AIDS Treat News; 1997 Feb 21; (No 265):3-4. PubMed ID: 11364240
    [Abstract] [Full Text] [Related]

  • 24. Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A, Vanprapar N, Sirimai K, Chearskul S, Sutthent R, Opartkiattikul N.
    Clin Infect Dis; 2002 Dec 01; 35(11):1405-13. PubMed ID: 12439805
    [Abstract] [Full Text] [Related]

  • 25. [One world in hope?].
    Esmel D, Bi ET, Kouamé J, Kerouedan D.
    Sante; 1997 Dec 01; 7(2):143-4. PubMed ID: 9273121
    [No Abstract] [Full Text] [Related]

  • 26. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar 10; 14(4):367-74. PubMed ID: 10770538
    [Abstract] [Full Text] [Related]

  • 27. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug 10; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 28. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
    Jankelevich S, Mueller BU, Mackall CL, Smith S, Zwerski S, Wood LV, Zeichner SL, Serchuck L, Steinberg SM, Nelson RP, Sleasman JW, Nguyen BY, Pizzo PA, Yarchoan R.
    J Infect Dis; 2001 Apr 01; 183(7):1116-20. PubMed ID: 11237839
    [Abstract] [Full Text] [Related]

  • 29. Ongoing open-label trials of triple therapy with stavudine and lamivudine or stavudine and didanosine plus nelfinavir.
    Anderson RD.
    Antivir Ther; 1998 Apr 01; 3 Suppl 4():63-4. PubMed ID: 10723514
    [Abstract] [Full Text] [Related]

  • 30. Kaletra versus nelfinavir.
    TreatmentUpdate; 2001 Apr 01; 12(12):8-10. PubMed ID: 11570097
    [No Abstract] [Full Text] [Related]

  • 31. Double protease inhibitor regimens with amprenavir show promise.
    AIDS Patient Care STDS; 1998 Apr 01; 12(4):317-8. PubMed ID: 11361962
    [No Abstract] [Full Text] [Related]

  • 32. Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection.
    Rabaud C, Burty C, Grandidier M, Christian B, Penalba C, Béguinot I, Jeanmaire H, May T.
    Clin Infect Dis; 2005 Jan 15; 40(2):303-5. PubMed ID: 15655751
    [Abstract] [Full Text] [Related]

  • 33. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
    Hoffmann F, Funk M, Linde R, Notheis G, Petropoulou T, Eberle J, Gürtler L, Belohradsky BH, Wintergerst U.
    Eur J Med Res; 2002 Jul 24; 7(7):330-4. PubMed ID: 12176683
    [Abstract] [Full Text] [Related]

  • 34. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
    Panburana P, Sirinavin S, Phuapradit W, Vibhagool A, Chantratita W.
    Am J Obstet Gynecol; 2004 Mar 24; 190(3):803-8. PubMed ID: 15042018
    [Abstract] [Full Text] [Related]

  • 35. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec 11; 145(50):60-1. PubMed ID: 14963980
    [No Abstract] [Full Text] [Related]

  • 36. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.
    Katz MH, Gerberding JL.
    N Engl J Med; 1997 Apr 10; 336(15):1097-100. PubMed ID: 9091810
    [No Abstract] [Full Text] [Related]

  • 37. Salvage with Nelfinavir doesn't always work.
    TreatmentUpdate; 1998 Aug 10; 10(6):2-3. PubMed ID: 11365702
    [Abstract] [Full Text] [Related]

  • 38. Triple-drug therapy may mean lifelong commitment.
    AIDS Alert; 1999 Jan 10; 14(1):3-5. PubMed ID: 11366090
    [Abstract] [Full Text] [Related]

  • 39. Study shows three drugs better than two.
    AIDS Alert; 1997 Apr 10; 12(4):39. PubMed ID: 11364145
    [Abstract] [Full Text] [Related]

  • 40. Amprenavir study results released.
    AIDS Patient Care STDS; 1999 Dec 10; 13(12):754. PubMed ID: 10743545
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.